To evaluate the clinical randomized controlled study of warming acupuncture combined with Western medicine in the treatment of chronic heart failure with Yang deficiency and blood stasis and observe its effect on inflammatory factors

Clinical randomized controlled study on the warming acupunctrue in treating chronic heart failure with Yang deficiency and blood stasis and its effect on inflammatory factors

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300078508

Enrollment

Unknown

Registered

2023-12-11

Start date

2023-12-11

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure

Interventions

treatment group:1.The patients are given warming needles.The point selection: bilateral Neiguan point, Xinshu point, Jueyin point, Shenshu point, Neiguan point, Yin Cleft point, Zusanli, Sanyin Jiao,

Metoprolo tattrate tablets

Empagliflozin tablets

spironolactone tablet

control group:Sacubactril valsartan tablets

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Western diagnostic criteria: meet the diagnosis of chronic heart failure 2. TCM diagnostic criteria: consistent with Yang deficiency and blood stasis type, chronic heart failure 3. Be between 18 and 80 years old 4. Heart function in Grade II-IV (NYHA) 5. Hemodynamic stability

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction, acute coronary syndrome, pericardial tamponade, cardiogenic shock and other factors increase mortality. 2 Patients with severe primary diseases of brain, liver, kidney and hematopoietic system and mental illness; 3 Heart failure caused by dilated cardiomyopathy, hypertrophic cardiomyopathy, rheumatic heart disease and other causes. 4 Pregnant or pregnant women, breastfeeding women. 5 Patients with previous acupuncture dizziness.

Design outcomes

Primary

Measure	Time frame
EF;NT-proBNP;	—

Secondary

Measure	Time frame
LVMI;IL-6;IL-1ß;hs-CRP;	—

Countries

China

Contacts

Public ContactWEN PEI

Jing'an District Hospital of Traditional Chinese Medicine (TCM)

pipi6050@163.com+86 139 1796 7467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026